Eclipsys (ECLP) Posts Q3 adj.-EPS of $0.14, Beats by 1c
More News related to ECLP
- Eclipsys to Present at the Piper Jaffray 21st Annual Health Care Conference
- Eclipsys Marks 50 Millionth Order at Sarasota Memorial Health Care System
- Singapore General Hospital Activates Eclipsys' Sunrise Patient Flow
- Caris & Co Upgrades Eclipsys (ECLP) to Above Average
- After-Hours Movers 11/05: JSDA, ENOC, SAM, RST, ASEI, KFN Higher; MOVE, FNM, CROX, BEBE, BID Lower
More News related to Earnings
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
Eclipsys (NASDAQ: ECLP) reports Q3 adjusted EPS of $0.14, 1 cent better than the analyst estimate of $0.13. Revenue for the quarter was $125.50 million, which compares to the estimate of $133.37 million.
Related Categories
EarningsStocks Mentioned
-0.77Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
